Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

17
Top Analyst Reports for Home Depot, UPS & Occidental Petroleum

2018-08-16 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Home Depot (HD), United Parcel Service (UPS) and Occidental Petroleum (OXY). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
SGEN HD CVS HSB CME MS HSBC HBCYF FOX UPS HCS 0005 7018 HSEA HSEB OXY FOXA

3
Mersana Therapeutics' (MRSN) CEO Anna Protopapas on Q2 2018 Results - Earnings Call Transcript

2018-08-15 seekingalpha
Good morning and welcome to the Mersana Therapeutics’ Second Quarter 2018 Financial Results Conference Call. Currently, all participants are in a listen-only mode. There will be a question-and-answer session at the end of this call.
SGEN MRSN

9
How Stemline's Latest Catalyst Shifts The Investment Thesis

2018-08-15 seekingalpha
The first area of interest is an unmet need, but it is also a rather rare tumor space.
SGEN STML

0
Bayer Plunges as Monsanto Fined $289M in Roundup Lawsuit

2018-08-14 zacks
Shares of Bayer AG (BAYRY - Free Report) went down almost 11% after its newly acquired subsidiary Monsanto was ordered by the California state jury to pay $289 million in damages over alleged links between its Roundup weedkiller and cancer.
SGEN VRTX GILD

0
Unum Therapeutics Inc. (UMRX) CEO Chuck Wilson on Q2 2018 Results - Earnings Call Transcript

2018-08-14 seekingalpha
Unum Therapeutics Inc. (NASDAQ:UMRX) Q2 2018 Results Earnings Conference Call August 13, 2018 5:00 PM ET
UMRX SGEN UNUM MS

0
Genmab A/S (GNMSF) CEO Jan van de Winkel on Q2 2018 Results - Earnings Call Transcript

2018-08-11 seekingalpha
Good day, and welcome to the Genmab First Half 2018 Financial Results Conference Call. Today's conference is being recorded. During this telephone conference, you may be presented with forward-looking statements that includes such words as believes, anticipates, plans or expects. Actual results may differ materially, for example, as a result of delayed or unsuccessful development projects. Genmab is not under any obligation to update statements regarding future, nor to confirm such statements in relation to actual results, unless this is required by law.
GNMSF SGEN GMXAY

10
Spectrum (SPPI) Earnings and Sales Miss Estimates in Q2

2018-08-11 zacks
Spectrum Pharmaceuticals, Inc. (SPPI - Free Report) incurred an adjusted loss of 21 cents per share in the second quarter of 2018, wider than the Zacks Consensus Estimate of a loss of 18 cents and the year-ago quarter loss of 11 cents per share.
SGEN GJV VRTX AMGN NWS NWSA SPPI

1
Pieris Pharmaceuticals. Inc (PIRS) CEO Stephen Yoder on Q2 2018 Results - Earnings Call Transcript

2018-08-09 seekingalpha
Greetings and welcome to the Pieris Pharmaceuticals 2018 Second Quarter Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
SGEN PIRS

0
Endo (ENDP) Beats on Q2 Earnings & Sales, Raises Guidance

2018-08-09 zacks
Shares of Endo International plc (ENDP - Free Report) gained 28.3% after the company reported better-than-expected second-quarter 2018 results. The company increased its outlook for the year.
SGEN VRTX GD ZTO ENL ENDP

0
Horizon Pharma (HZNP) Q2 Earnings & Sales Beat, Shares Rise

2018-08-09 zacks
Horizon Pharma plc (HZNP - Free Report) reported better-than-expected results for the second quarter of 2018. Following the news, the company’s shares went up 10.7%. Horizon Pharma’s stock price has increased 37.8% year to date against the industry’s fall of 4.6%.
SGEN VRTX GILD UCTI HZNP UCTT

13
Sarepta (SRPT) Q2 Loss Narrows, Exondys 51 Drives Sales

2018-08-09 zacks
Sarepta Therapeutics, Inc. (SRPT - Free Report) incurred a loss of 43 cents per share in the second quarter of 2018, narrower than the year-ago loss of 48 cents and the Zacks Consensus Estimate of a loss of 47 cents.
SGEN VRTX REGN SRPT UCTI UCTT

0
Perrigo (PRGO) Beats on Q2 Earnings, Cuts View, Shares Down

2018-08-09 zacks
Perrigo Company plc (PRGO - Free Report) reported second-quarter 2018 adjusted earnings of $1.22 per share, which beat the Zacks Consensus Estimate of $1.21. Earnings growth was flat year over year.
SGEN VRTX PRGO UCTI OTCB UCTT

24
Nektar (NKTR) Q2 Earnings In Line, Product Sales Down Y/Y

2018-08-09 zacks
Nektar Therapeutics (NKTR - Free Report) reported earnings of $5.33 per share in the second quarter of 2018, matching the Zacks Consensus Estimate. The company had recorded a loss of 39 cents per share in the year-ago period.
SGEN NKTR UCTI UCTT

1
Celldex (CLDX) Q2 Earnings and Revenues Surpass Estimates

2018-08-09 zacks
Celldex Therapeutics, Inc. (CLDX - Free Report) incurred second-quarter 2018 loss of 11 cents per share, narrower than the Zacks Consensus Estimate of a loss of 14 cents and the year-ago loss of 23 cents.
SGEN CLDX UCTI UCTT

2
Mallinckrodt (MNK) Beats on Q2 Earnings and Sales, Ups View

2018-08-08 zacks
Shares of Mallinckrodt Public Limited Company (MNK - Free Report) are up 20.9% after the company reported strong results for the second quarter of 2018 and upped its annual guidance. Performance of hospital products especially Inomax and Ofirmev were impressive.
SGEN VRTX OAS BAX SCMP

Related Articles

RNVA: Rennova Health Analysis and Research Report

7h - Asif

Business overview Rennova Health, Inc. (together with its subsidiaries, “Rennova”, “we” or the “Company”) is a provider of an expanding group of health care services for healthcare providers, patients and individuals. Beginning in 2018, the Company intends to focus on and operate two synergistic divisions: 1) Clinical diagnostics through its clinical laboratories; and 2) Hospital operations through its Big South Fork Medical Center, which opened on August 8, 2017, and a hospital in Jamestown Tennessee, including a doctor’s practice, the assets of which the company expect to acquire in the second quarter of 2018, pursuant to the terms of a definitive asset purchase agreement that the company entered into on January 31, 2018, as more fully discussed below. The company believe that its approach will produce a more sustainable business model and the capture of multiple revenue streams from medical providers, patients and hospital services. Management determined that because Big So...

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

CUSIP: 812578102